Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Zydus Lifesciences acquires Sterling Biotech assets

RECENTLY ACQUIREDAug 05, 2026•4 days ago

Acquiring Company

Zydus Lifesciences

Acquired Company

Sterling Biotech

MumbaiHealth CareMedicalManufacturingBiotechnology

Description

Zydus Lifesciences is acquiring pharmaceutical assets of Sterling Biotech in a multi-stage deal reported at $150 million. Sterling Biotech specializes in fermentation-derived APIs and has been a key player in pharmaceutical manufacturing since 1985. The acquisition will bolster Zydus's portfolio in oncology support. The transaction follows a joint venture relationship established previously.

Company Information

Company

Zydus Lifesciences

About

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd. Zydus has always been a purpose driven company. It has been our legacy of keeping patients and caregivers at the heart of everything we do. Backed by innovation, we have been exploring novel approaches in healthcare. As we continue to make a meaningful difference in the lives of patients, we hope to empower them and help them lead  healthier and more fulfilled lives.

Predictive Intelligence
Strategic

ML-powered predictions for Zydus Lifesciences's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.